Cover Image

Neutrophil-to-lymphocyte ratio and chemotherapy response score as prognostic markers in ovarian cancer patients treated with neoadjuvant chemotherapy

Research highlights Biomarkers that would predict response to neoadjuvant chemotherapy in advanced ovarian cancer patients are eagerly needed: • Neutrophil to Lymphocyte Ratio (NLR) is an indicator of systemic inflammatory response to the malignancy. • NLR was evaluated in 132 patients undergoing Ne...

Full description

Saved in:

Bibliographic Details
Main Authors:	M. Liontos (Author), A. Andrikopoulou (Author), K. Koutsoukos (Author), C. Markellos (Author), E. Skafida (Author), O. Fiste (Author), M. Kaparelou (Author), N. Thomakos (Author), D. Haidopoulos (Author), A. Rodolakis (Author), M. A. Dimopoulos (Author), F. Zagouri (Author)
Format:	Book
Published:	BMC, 2021-11-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Subarachnoid hemorrhage in a postpartum mother: A rare manifestation of an uncommon disease
by: Oraianthi Fiste, et al.
Published: (2022)

Pretreatment neutrophil-to-lymphocyte ratio and its dynamic change during neoadjuvant chemotherapy as poor prognostic factors in advanced ovarian cancer
by: Yun-Ji Kim, et al.
Published: (2018)

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
by: Michalis Liontos, et al.
Published: (2020)

Association between alteration of neutrophil to lymphocyte ratio, platelet to lymphocyte ratio, cancer antigen-125 and surgical outcomes in advanced stage ovarian cancer patient who received neoadjuvant chemotherapy
by: Ponganun Tuntinarawat, et al.
Published: (2024)

What to expect from paraneoplastic syndromes of the nervous system in uterine cancer: A review of the literature
by: Anna Svarna, et al.
Published: (2023)

Prognostic significance of baseline T cells, B cells and neutrophil-lymphocyte ratio (NLR) in recurrent ovarian cancer treated with chemotherapy
by: Jon Røikjær Henriksen, et al.
Published: (2020)

Breast cancer prognostication with neutrophil-lymphocyte ratio and platelet-lymphocyte ratio
by: Taha Bahgat
Published: (2017)

Impact of CDK4/6 Inhibitors on Aromatase Inhibitor-Associated Musculoskeletal Syndrome (AIMSS) in the Adjuvant Setting
by: Efthymia Skafida, et al.
Published: (2023)

Paraneoplastic cerebellar degeneration in platinum-responsive endometrial cancer: A case report and review of literature
by: Michalis Liontos, et al.
Published: (2021)

Neutrophil/lymphocyte and platelet/lymphocyte ratio and outcome after first chemotherapy of patients with breast cancer in a city of Minas Gerais
by: Priscilla Brunelli PUJATTI, et al.
Published: (2024)

Neoadjuvant Chemotherapy Current Applications in Clinical Practice
Published: (2012)

Neoadjuvant Chemotherapy Increasing Relevance in Cancer Management
Published: (2013)

Metastatic Hepatic Epithelioid Hemangioendothelioma Treated with Olaratumab: A Falling Star Rising?
by: Kyriazoglou A, et al.
Published: (2020)

Retrospective analysis of bevacizumab-induced arthralgia and clinical outcomes in ovarian cancer patients. Single center experience
by: Maria Kaparelou, et al.
Published: (2022)

The use of neoadjuvant chemotherapy in advanced endometrial cancer
by: L. Philp, et al.
Published: (2021)

Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio reliable parameters as prognostic indicators in malignant mesothelioma?
by: Tural Onur S, et al.
Published: (2016)

Prognostic Value of the Neutrophil-to-lymphocyte Ratio, Platelet-to- lymphocyte Ratio and Monocyte-to-lymphocyte Ratio in Melanoma Patients: A Cohort Study
by: Sümeyre Seda Ertekin, et al.
Published: (2024)

Platelet to Lymphocyte Ratio and Neutrophil to Lymphocyte Ratio in Missed Abortion
by: Ismail Biyik, et al.
Published: (2020)

Neutrophil to Lymphocyte Ratio in Preeclampsia
by: Alfian Prasetyo, et al.
Published: (2021)

Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients
by: Gysllene M. C. Brito, et al.
Published: (2021)

CD4+ Tumor-infiltrating Lymphocytes in Neoadjuvant Chemotherapy-treated Invasive Breast Cancer of No Special Type
by: Primariadewi Rustamadji, et al.
Published: (2024)

Tumor-infiltrating CD8+ and FOXP3+ lymphocytes before and after neoadjuvant chemotherapy in cervical cancer
by: Yun Liang, et al.
Published: (2018)

Predictive value of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in decompensated heart failure
by: Mahmoud Ashry, et al.
Published: (2019)

Neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio as predictive markers in hepatoblastoma
by: Tan Xie, et al.
Published: (2023)

Correlation of the value of sonoelastography strain ratio with the degree of pathological regression in patients with locally advanced breast cancer undergoing neoadjuvant chemotherapy
by: E. A. Bus'ko, et al.
Published: (2017)

Evaluation of the Efficacy of Neoadjuvant Chemotherapy for Breast Cancer
by: Wang H, et al.
Published: (2020)

Prognostic value of rise in neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in predicting the mortality in pediatric intensive care
by: Siby Mathews, et al.
Published: (2018)

Neutrophil-lymphocyte and Platelet-lymphocyte Ratios in Febrile Seizures
by: Sonay İncesoy Özdemir, et al.
Published: (2022)

Neoadjuvant chemotherapy for advanced ovarian cancer: literature data and in vitro studies
by: S. A. Kuznetsov, et al.
Published: (2015)

The Use of Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio and Platelets-to-Lymphocyte Ratio in the Assessment of the Risk of Conversion and Complications After Cholecystectomy Performed Due to Symptomatic Cholelithiasis
by: Molasy B, et al.
Published: (2024)

Evaluation of neutrophil-to-lymphocyte ratio and platelet-to-lymphocyte ratio in chronic plaque psoriasis
by: Sudeshna Mondal, et al.
Published: (2022)

Increased Neutrophil-Lymphocyte Ratio and Platelet-Lymphocyte Ratio in Chronic and Severe Urticaria
by: Sarah Weissmann, et al.
Published: (2024)

Predictive role of platelets to lymphocytes ratio and neutrophil to lymphocytes ratio in COPD exacerbation
by: Hussien Fayiad, et al.
Published: (2024)

The Correlation Between Platelet-to-Lymphocyte Ratio and Neutrophil-to-Lymphocyte Ratio with Hepatic Echinococcosis
by: E Weijian, et al.
Published: (2021)

Pembrolizumab and Chemotherapy Combination Prolonged Progression-Free Survival in Patients with NSCLC with High PD-L1 Expression and Low Neutrophil-to-Lymphocyte Ratio
by: Jeng-Shiuan Tsai, et al.
Published: (2022)

Prediction of severity of preeclampsia in Egyptian patients: role of neutrophil/lymphocyte ratio, platelet/lymphocyte ratio and C-reactive protein
by: A. E. Kholeif, et al.
Published: (2020)

Prognostic Value of Neutrophil-Lymphocyte Ratio, Platelet-Lymphocyte Ratio and Systemic Immune-Inflammatory Index in Resected Gastric Cancer
by: Hayriye Şahinli, et al.
Published: (2019)

Prognostic Value of the Pretreatment Neutrophil-to-Lymphocyte Ratio in Pediatric Parotid Cancer
by: Dongjie Seng, et al.
Published: (2019)

Prognostic Relevance of Pretreatment Peripheral Neutrophil Count and Neutrophil-to-lymphocyte Ratio in Primary Cutaneous Angiosarcoma
by: Kentaro Awaji, et al.
Published: (2021)

Impact of various options of neoadjuvant chemotherapy on the hormonal status of patients with breast cancer
by: Yu. S. Sidorenko, et al.
Published: (2014)